Results 151 to 160 of about 1,394,435 (222)

Immune suppression, HLA-risk and potential future immune based targets of oral leukoplakia progression. [PDF]

Front Dent Med
Soni M, DeSantis B, Villa A, Kamoun M, Gates J.   +4 more
europepmc   +1 more source

Salivary Oxidative Stress and Antioxidant Markers in Oral Leukoplakia: A Systematic Review and Meta-Analysis. [PDF]

Antioxidants (Basel)
Wiśniewski P, Sulewska M, Rybaczek Z, Szymańska K, Nowakowska J, Chrobot M, Podedworna M, Doroszczyk K, Murtaś P, Pietruska M.   +9 more
europepmc   +1 more source

Efficacy of 5-ALA Photodynamic Therapy in Dysplastic Oral Leukoplakia: Systematic Review and Meta-Analysis. [PDF]

Pharmaceutics
Sulewska M, Wiśniewski P, Stępniewska M, Poloczek Z, Chodziński D, Melion P, Pawluczuk M, Pietruska A, Pietruska M.   +8 more
europepmc   +1 more source

Cancer Hallmarks Expression in Oral Leukoplakia: Systematic Review and Meta-Analysis. [PDF]

Oral Dis
González-Ruiz I, Ramos-García P, Boujemaoui-Boulaghmoudi H, Mjouel-Boutaleb N, González-Moles MA.   +4 more
europepmc   +1 more source

[Preliminary investigation into the mechanisms of thalidomide in inhibiting the malignant transformation of oral leukoplakia]. [PDF]

Hua Xi Kou Qiang Yi Xue Za Zhi
Shang Q, Awuti G, Xu H, Chen Q, Zhao J.
europepmc   +1 more source

Randomized Controlled Trials for Oral Leukoplakia. [PDF]

Oral Dis
Lodolo M, Lodolo M, Valor J, Villa A.
europepmc   +1 more source

Dual activation of cuproptosis and excessive autophagy by copper-bismuth metal-organic frameworks-loaded detachable microneedles in oral leukoplakia. [PDF]

Mater Today Bio
Zhou K, Gao M, Wan Y, Cong B, Zhu T, Ye Z, Zhang T, Wang W.   +7 more
europepmc   +1 more source

Descriptive transcriptomic profiling differentiates oral leukoplakia from proliferative verrucous leukoplakia and reveals distinct molecular signatures. [PDF]

Med Oral Patol Oral Cir Bucal
Pérez-Sayáns M, Vieira-E-Silva FF, Fernández-Rozadilla C, Carracedo Á, Carlés-González S, Lorenzo-Pouso AI, Pérez-Jardón A, Gándara-Vila P, García-García A, Suárez-Peñaranda JM, Blanco-Carrión A, Chamorro-Petronacci CM.   +11 more
europepmc   +1 more source

Assessment of Promoter Hypermethylation in Tumor Suppressor Genes in Oral Leukoplakia and Oral Submucous Fibrosis. [PDF]

J Pharm Bioallied Sci
Abdul NS, Mhaske S, Afroz S, Nigam S, Jyoti B, Singaraju S, Shivakumar S, Channaiah SG.   +7 more
europepmc   +1 more source

Azoxystrobin induces mitochondrial dysfunction and mitochondrial pathway apoptosis by targeting the Prx1 Trp87 and Thr90 sites in oral leukoplakia. [PDF]

Front Pharmacol
Li W, Shen Y, Li L, Wang M, Zhang M, Tang X.   +5 more
europepmc   +1 more source